Navigation Links
Good Neighbor Pharmacy(R) Ironman Competitor Inspires Individuals with Diabetes to Live Without Limits
Date:1/17/2008

Andy is he just gets my son and everything he's going through, and he can provide the support and encouragement that Drake needs living with diabetes."

Stories like Rochelle's have been captured on a Good Neighbor Pharmacy program website -- Diabetes Shoppe's http://livingwithoutlimits.diabetes-shoppe.com. The site will profile a number of people who have been inspired by Andy's story. The website also posts Andy's schedule for the upcoming year.

Feb. 2: Sandy, Utah; ADA Expo Salt Lake City

Mar. 29: Oceanside, Calif.; Ford Ironman 70.3

Apr. 13: Tempe, Ariz.; Ford Ironman Arizona

May 4: Cincinnati, Ohio; Flying Pig Marathon

For more information about the Managing Diabetes: Living Without Limits Campaign, visit http://livingwithoutlimits.diabetes-shoppe.com. Information is also available at Diabetes Shoppe, located inside Good Neighbor Pharmacies across the country.

About AmerisourceBergen(R), Good Neighbor Pharmacy(R) and Diabetes Shoppe(R)

Good Neighbor Pharmacy, an AmerisourceBergen program, is a network of nearly 2,800 independently owned and operated community pharmacies. Diabetes Shoppe offers marketing and educational support to independent pharmacies that are dedicated to the care and management of diabetes patients. There are currently over 1,000 Diabetes Shoppe members, located in independent pharmacies nationwide. Diabetes Shoppe is an offering of AmerisourceBergen.

AmerisourceBergen is one of the world's largest pharmaceutical services companies serving the United States, Canada and selected global markets. Servicing both pharmaceutical manufacturers and healthcare providers in the pharmaceutical supply channel, the Company provides drug distribution and related services designed to reduce costs and improve patient outcomes. AmerisourceBergen
'/>"/>

SOURCE Good Neighbor Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Good Neighbor Pharmacy Joins with Diversified Racing Solutions to Enter NASCAR Nationwide Series in 2008
2. Roche Real-Time HIV Test is Faster and Less Labor-Intensive Than Competitors
3. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
4. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
5. Novo Nordisk Applauds Adoption of World Diabetes Day Resolutions by U.S. Congress
6. International Diabetes Experts Call for Stepped-Up Action and Shared Responsibility to Curb Rising Global Diabetes Epidemic and Impact
7. World Think Tank on Type 1 Diabetes Meets in Miami
8. New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the Holidays
9. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
10. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
11. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)...y Technology Receive Funding, From Allied Minds to... of Aliquots, BOST...d investment,corporation specializing in early sta...y,s Office of Technology Development, and Northeas...t Instruments, LLC, a new,spin-out focused on the ...
(Date:7/2/2008)...-- Pearl Therapeutics, Inc.,a biopharmaceutical c...iseases, today announced that it has completed the...s financing was executed as an extension to,its fi...articipating in the,internal round were Pearl,s ex...s, 5AM Ventures and Nektar Therapeutics. In total,...
(Date:7/2/2008)...-- Research conducted at The,Walter and Eliza Hall... a,major licensing agreement signed between Austra...nd Germany-based pharmaceutical company, Merck,Ser...nt, Merck Serono will seek,to develop new treatmen...e,conditions. These prospective treatments will be...
(Date:7/2/2008).../ -- WuXi PharmaTech (NYSE:,WX), a leading pharmac...,and development outsourcing company with operatio... that it has appointed Mr. Bob Zhu as Vice Preside...m.com/cgi-bin/prnh/20040705/CNM002LOGO ), Prior ... of Asia Human,Resources with Electronic Arts (EA)...
Breaking Biology Technology:Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors 2MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR 2
...echnology , a unit of Fisher Biosciences, has cont... to distribute GenTel,s trademarked PATH brand thi...use of GenTel technology in developing new protein...ry. GenTel slides are specifically designed for pr...of disease biomarkers to improve the safety and ef...
...th the recently developed APR reactor UW-Madison ...s. In 2002, UW stem cell pioneer James Thomson w...ge and Sergey Brin. This year, it might be James D... two men will be honored as New Fellows of the New...s itself a "global meeting ground, a virtual think...
...nst CoreComm Voyager, Inc . for violating Wiscons... by the state attorney general. , ,CoreComm, a Del...s and related services to Wisconsin customers, man...nsin-based internet provider subsequently acquired...y Circuit Court, alleged that CoreComm failed to c...
...ebsite for the new century, complete with RSS news...s of everything important to the average person, s...ses and changes in the status of known sex offende...ted shades of gray, blue and tan. It contains link...et a free credit report, and gives up-to-the minut...
Other Biology Technology:Wisconsin scientists to be recognized for innovative biofuel technology 2Wisconsin scientists to be recognized for innovative biofuel technology 3CoreComm slapped by AG for violating telecommunications laws 2State web site needs overhaul 2State web site needs overhaul 3State web site needs overhaul 4
(Date:7/3/2008)...hers at the David Geffen School of Medicine at UCL... known as sodium glucose co-transporters (SGLTs), ...teins are used in the treatment of chronic diarrhe...f millions of children each year. The solution of ...new drugs designed to treat patients with diabetes...
(Date:7/3/2008)...bservation satellites have provided vital informat...icularly long crisis response window following the...n 2 and 3 May 2008. , Immediately after the disa...tarian Affairs (OCHA) asked the International Char... ,the Charter, for support by providing immediate...
(Date:7/3/2008)...IS Want to slow the signs of aging and live longe...tting back on calories could be a promising strate...o slow the aging process in rats and mice. While s...cts the aging process in rodents, one popular hypo...oid hormone, triiodothyronine (T3), which then slo...
(Date:7/2/2008)...GSTON, R.I. July 2, 2008 Standing in a greenhous... was smiling even though it appeared that somethin...pecies of grass she planted last February in hundr...ofessor of turf science wasn,t surprised. That,s ...saltier water for five months, and few varieties o...
Breaking Biology News(10 mins):UCLA researchers clarify function of glucose transport molecule 2Extended cyclone relief efforts aided from space 2Extended cyclone relief efforts aided from space 3Looking for the Founatain of Youth? Cut your calories, research suggests 2Search for salt tolerant grasses aims to improve roadside plantings 2Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 1Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 2Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 3Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 4Access Pharmaceuticals Announces 242 7 Million New Equity 2811 1Access Pharmaceuticals Announces 242 7 Million New Equity 2811 2Access Pharmaceuticals Announces 242 7 Million New Equity 2811 3Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 1Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 2Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 3Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 4Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads 2809 1Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads 2809 2
...diers guarding a castle gate, multiple genetic def...wdery mildew disease, according to a new study. Po...s that attacks more than 9,000 species, including ...ural plants such as roses and cucumbers. The resea...in of the Carnegie Institution,s Department of Pla...
...reatment for stroke has taken a major step forward...al trial. , Researchers at The University of Manch...rally occurring protein called IL-1ra protects bra...y Professor Nancy Rothwell and Dr Pippa Tyrrell, h...ial of IL-1ra in patients, which are published in ...
...t accompanied the recent drought was the underlyin...ughout the Southwest, according to new research. ,...osystem for decades. Hotter temperatures coupled w...bal climate change models. The new finding suggest...global climate change. , "We documented a massive...
...e experiment has resulted in one of the longest re...ened a new door for anti-aging research in humans.... extra copy of the SIR2 gene can promote longevity...was covered widely and incorporated into anti-agin...gy companies. , Now, molecular geneticists at the...
Other Biology News:Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3Stroke treatment a step closer after trial 2Underlying cause of massive pinyon pine die-off revealed 2Underlying cause of massive pinyon pine die-off revealed 3Underlying cause of massive pinyon pine die-off revealed 4New technique multiplies life span in simple organisms 2New technique multiplies life span in simple organisms 3
Rabbit polyclonal to TAB1 ( Abpromise for all tested applications). entrezGeneID: 10454 SwissProtID: Q15750
Rabbit polyclonal to NIRF ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from residues 186-235 of human NIRF. Entrez Gene ID: 115426 Swiss Protein ID: Q96PU
Rabbit polyclonal to DcR2 ( Abpromise for all tested applications). entrezGeneID: 8793 SwissProtID: Q9UBN6
Fau I from New England Biolabs
Biology Products: